RESUMEN
Local treatment after resection to inhibit glioma recurrence is thought to able to meet the real medical needs. However, the only clinically approved local glioma treatment-wafer containing bis(2-chloroethyl) nitrosourea (BCNU) showed very limited effects. Herein, in order to inhibit tumor recurrence with prolonged and synergistic therapeutic effect of drugs after tumor resection, an in situ dual-sensitive hydrogel drug delivery system loaded with two synergistic chemo-drugs BCNU and temozolomide (TMZ) was developed. The thermosensitive hydrogel was loaded with reactive oxygen species (ROS)-sensitive poly (lactic-co-glycolic) acid nanoparticles (NPs) encapsulating both BCNU and TMZ and also free BCNU and TMZ. The in vitro synergistic effect of BCNU and TMZ and in vivo presence of ROS at the residual tumor site were confirmed. The prepared ROS-sensitive NPs and thermosensitive hydrogel, as well as the long-term release behavior of drugs and NPs, were fully characterized both in vitro and in vivo. After >90% glioblastoma resection, the dual-sensitive hydrogel drug delivery system was injected into the resection cavity. The median survival time of the experimental group reached 65 days which was twice as long as the Resection only group, implying that this in situ drug delivery system effectively inhibited tumor recurrence. Overall, this study provides new ideas and strategies for the inhibition of postoperative glioma recurrence.
Asunto(s)
Neoplasias Encefálicas , Glioma , Neoplasias Encefálicas/tratamiento farmacológico , Neoplasias Encefálicas/patología , Neoplasias Encefálicas/cirugía , Carmustina/uso terapéutico , Línea Celular Tumoral , Glioma/tratamiento farmacológico , Glioma/patología , Glioma/cirugía , Humanos , Hidrogeles/uso terapéutico , Recurrencia Local de Neoplasia/tratamiento farmacológico , Especies Reactivas de Oxígeno , TemozolomidaRESUMEN
An organic-inorganic hybrid monolith incorporated with titanium dioxide nanotubes (TNTs) and hydrophilic deep eutectic solvents (DESs) was prepared and evaluated by the isolation of proteins using solid phase microextraction. A typical polymerization system was composed of choline chloride/methacrylic acid (ChCl/MAA, DESs monomer), glycidyl methacrylate (GMA), as well as ethylene glycol dimethacrylate (EDMA) in the presence of TNTs. Then the epoxy groups on the surface of the resulting monolith were modified with amino groups. The synergistic effect of TNTs and DESs monomer to improve the enrichment performance of the sorbent significantly was demonstrated. Compared with the corresponding TNTs/DESs-free monolith, the recoveries of BSA and OVA were increased to 98.6% and 92.7% (RSDs < 2.0%), with an improvement of more than 60.0%. With a correlation coefficient of determination (R2) higher than 0.9995, the enrichment factors (EFs) were 21.9-28.3-fold. In addition, the resulting monolith was further applied to specifically capture proteins from rat liver according to their pI value, followed by HPLC-MS/MS analysis. The results indicated that the developed monolith was an effective material to isolate protein species of interest according to the pI value of target proteins.
Asunto(s)
Nanotubos , Polímeros , Solventes , Espectrometría de Masas en Tándem , TitanioRESUMEN
PURPOSE: The incidence of breast cancer worldwide has been on the rise since the late 1970s, and it has become a common tumor that threatens women's health. Aminoglutethimide (AG) is a common treatment of breast cancer. However, current treatments require frequent dosing that results in unstable plasma concentration and low bioavailability, risking serious adverse reactions. Our goal was to develop a molecularly imprinted polymer (MIP) based delivery system to control the release of AG and demonstrate the availability of this drug delivery system (DDS), which was doped with carbon nanotube with aid of metal-organic gel. METHODS: Preparation of MIP was optimized by key factors including composition of formula, ratio of monomers and drug loading concentration. RESULTS: By using multi-walled carbon nanotubes (MWCNT) and metal-organic gels (MOGs), MIP doubled the specific surface area, pore volume tripled and the IF was 1.6 times than the reference. Compared with commercial tablets, the relative bioavailability was 143.3% and a more stable release appeared. CONCLUSIONS: The results highlight the influence of MWCNT and MOGs on MIP, which has great potential as a DDS.
Asunto(s)
Aminoglutetimida/química , Antineoplásicos Hormonales/química , Complejos de Coordinación/química , Sistemas de Liberación de Medicamentos/métodos , Nanotubos de Carbono/química , Aminoglutetimida/administración & dosificación , Aminoglutetimida/farmacocinética , Animales , Antineoplásicos Hormonales/administración & dosificación , Antineoplásicos Hormonales/farmacocinética , Complejos de Coordinación/administración & dosificación , Compuestos Férricos/química , Geles/administración & dosificación , Geles/química , Humanos , Células MCF-7 , Masculino , Impresión Molecular/métodos , Ratas , Ácidos Tricarboxílicos/químicaRESUMEN
Molecularly imprinted polymers (MIPs) have drawn extensive attention as carriers on drug delivery. However, most of MIPs suffer from insufficient drug loading capacity, burst release of drugs and/or low bioavailability. To solve the issues, this study designed an imprinted material with superior floating nature for oral drug delivery system of capecitabine (CAP) rationally. The MIPs was synthesized in the presence of 4-methylphenyl dicyclohexyl ethylene (liquid crystalline, LC) and polyhedral oligomeric silsesquioxanes (POSS) via polymerization reaction. The LC-POSS MIPs had extended release of the template molecules over 13.4â¯h with entrapment efficiency of 20.53%, diffusion coefficient of 2.83â¯×â¯10-11â¯cm2â¯s-1, and diffusion exponent of 0.84. Pharmacokinetic studies further revealed the prolong release and high relative bioavailability of CAP in vivo of rats, showing the effective floating effect of the LC-POSS MIPs. The in vivo images revealed visually that the gastroretentive time of the LC-POSS MIPs was longer than non-LC-POSS imprinted polymers. The physical characteristics of the polymers were also characterized by nitrogen adsorption experiment, scanning electron microscopy, thermogravimetric analysis and differential scanning calorimetry analysis. As a conclusion, the LC-POSS MIPs can be used as an eligible CAP carrier and might hold great potential in clinical applications for sustained release drug.
Asunto(s)
Antimetabolitos Antineoplásicos/administración & dosificación , Capecitabina/administración & dosificación , Impresión Molecular , Compuestos de Organosilicio/administración & dosificación , Polímeros/administración & dosificación , Animales , Antimetabolitos Antineoplásicos/química , Antimetabolitos Antineoplásicos/farmacocinética , Capecitabina/química , Capecitabina/farmacocinética , Supervivencia Celular/efectos de los fármacos , Preparaciones de Acción Retardada/administración & dosificación , Preparaciones de Acción Retardada/química , Preparaciones de Acción Retardada/farmacocinética , Liberación de Fármacos , Humanos , Cristales Líquidos/química , Células MCF-7 , Masculino , Modelos Moleculares , Compuestos de Organosilicio/química , Compuestos de Organosilicio/farmacocinética , Polímeros/química , Polímeros/farmacocinética , Ratas WistarRESUMEN
The facile fabrication of single-walled carbon nanotubes (SWCNTs)-doping molecularly imprinted polymer (MIP) nanocomposite-based binary green porogen system, room-temperature ionic liquids (RTILs), and deep eutectic solvents (DESs) was developed for drug delivery system. With fenbufen (FB) as template molecule, 4-vinylpyridine (4-VP) was used as functional monomer, ethylene glycol dimethacrylate as cross-linking monomer, and 1-butyl-3-methylimidazoliumtetrafluoroborate and choline chloride/ethylene glycol as binary green solvent, in the presence of SWCNTs. The imprinting effect of the SWCNT-MIP composites was optimized by regulation of the amount of SWCNTs, ratio of RTILs and DES, and the composition of DES. Blue shifts of UV bands strongly suggested that interaction between 4-VP and FB can be enhanced due to SWCNT doping in the process of self-assembly. The reinforced imprinted effect of CNT-doping MIP can provide superior controlled release characteristics. Compared with the control MIP prepared without SWCNTs, the imprinting factor of the SWCNT-MIP composites exhibited a twofold increase. In the analysis for the FB release kinetics from all samples, the SWCNT-reinforced MIP produced the lowest value of drug diffusivity. The relative bioavailability of the SWCNT-MIP composites (F %) displayed the highest value of 143.3% compared with the commercial FB tablet, whereas the control MIP and SWCNT-non-MIP composites was only 48.3% and 44.4%, respectively. The results indicated that the SWCNT-MIP nanocomposites developed here have potentials as the controlled-release device.